Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
12 Sep - 20 Oct 2005
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005
Report date:
2005

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
- Principle of test: Repeated Insult Patch Test in Humans
- Short description of test conditions:
- Parameters analysed / observed: skin reaction after application of the test substance
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
N-[3-(dimethylamino)propyl]docosanamide
EC Number:
262-134-8
EC Name:
N-[3-(dimethylamino)propyl]docosanamide
Cas Number:
60270-33-9
Molecular formula:
C27H56N2O
IUPAC Name:
N-[3-(dimethylamino)propyl]docosanamide

Method

Type of population:
other: volunteers
Ethical approval:
not specified
Subjects:
- Number of subjects exposed: 52
- Sex: male and female
- Age: 16 - 74 years
Clinical history:
- Other: Only males and females were chosen for the study, which had no skin disease and were not using any topical or sytemic steroids and/ or antihistamines for at least one week prior to the study initiation. In addition, they had to fill out a medical history form (no further information provided on the content of these forms).
Route of administration:
dermal
Details on study design:
TYPE OF TEST(S) USED: patch test (epicutaneous test)

ADMINISTRATION
- Type of application: semiocclusive
- Description of patch: clear adhesive dressing (TruMed Technologies, Inc., Burnsville, USA)
- Concentrations: 5% aquatic solution
- Volume applied: 0.2 mL, applied on 1" x 1" absorbent pad portion of the clear adhesive dressing
- Testing/scoring schedule:
Induction phase: Patches were applied 3 times per week for a total of 9 applications. The evaluation of this site was made prior to re-application. Rest periods consisted of 24 h following each removal on Tuesdays and Thursdays, and 48 h following each removal on Saturdays.
Challenge phase: 2 weeks after final induction patch application a challenge patch was applied to a test site adjacent to the induction patch site. After 24 h the patch was removed and the site was scored. An additional reading was performed after 72 h post application.
- Removal of test substance: 24 h after application
- Other: If a participant was unable to show up on the assigned test day, 1 makeup day was permitted. This day was added to the induction period.
If any test site showed a moderate reaction (scored 2) during the induction phase, the application would be moved to an adjacent area (except of the first supervised induction patch reading). Applications would be discontinued, if a moderate reaction (scored 2) was observed on the new test site aswell and/ or if marked or severe reactions (scored 3 or 4, respectively) were noted.

EXAMINATIONS
- Grading/Scoring system:
0 = no visible skin reaction
+ = barely perceptible or spotty erythema
1 = mild erythema covering most of the test site
2 = moderate erythema, possible presence of mild edema
3 = marked erythema, possible edema
4 = severe erythema, possible edema, vesiculation, bullae and/or ulceration

Results and discussion

Results of examinations:
NO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION
- Number of subjects with positive reactions: 0/ 52
- Number of subjects with negative reactions: 52/ 52

Applicant's summary and conclusion

Conclusions:
CLP: not classified